Keywords: Teva Pharmaceutical Industries, Financial results, Fourth-quarter and full-year 2012

Teva Pharma's 4th-qtr financials just misses forecasts

Article | 08 February 2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) reported results for the fourth quarter 2012, posting non-GAAP operating income of $1.3 billion, down 22% compared ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Teva Pharmaceutical Industries

Go to company listing